Your session is about to expire
← Back to Search
Nurse-Led Palliative Care for COPD
N/A
Waitlist Available
Research Sponsored by University of Alabama at Birmingham
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Must not have
Patient participant will be excluded if they had a recent hospitalization for any reason or exacerbation of COPD in the past 30 days or ongoing exacerbation symptoms requiring treatment with antibiotics and steroids
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new way to provide palliative care to people with COPD before the end of life.
Who is the study for?
This trial is for older adults over 60 with moderate to very severe COPD, confirmed by spirometry tests. Participants must speak English and have a care partner willing to join the study. They should experience severe breathlessness or have had a hospitalization in the past year but not within the last 30 days, or be on supplemental oxygen. People with recent hospitalizations, certain cognitive impairments, advanced cancers, active major psychiatric disorders or substance abuse issues, other primary lung diseases, or non-correctable hearing impairment cannot participate.
What is being tested?
The EPIC pilot RCT is testing an early palliative care intervention called EPIC for older adults with COPD and their care partners against usual COPD care alone. The intervention involves nurse coaches delivering a curriculum via phone sessions followed by monthly follow-ups to improve quality of life and reduce healthcare utilization.
What are the potential side effects?
Since this trial focuses on palliative education and support rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort when discussing sensitive topics related to their illness during coaching sessions.
Eligibility Criteria
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I haven't been hospitalized or had severe COPD symptoms needing treatment in the last 30 days.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months, 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability (Qualitative)
Acceptability (Quantitative)
Intervention Feasibility
+1 moreSecondary study objectives
Chronic Respiratory Questionnaire (CRQ)
De Jon Gierveld Loneliness Scale
Healthcare and palliative care utilization
+7 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention (EPIC plus Usual COPD Care)Experimental Treatment1 Intervention
Participants randomized to this arm will receive the experimental treatment for COPD (i.e. EPIC plus usual COPD care).
Group II: Usual COPD CareActive Control1 Intervention
Participants randomized to this arm will receive the standard of care for COPD.
Find a Location
Who is running the clinical trial?
University of Alabama at BirminghamLead Sponsor
1,643 Previous Clinical Trials
2,342,340 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am 60 years old or older.My care partner does not have untreated mental health issues or substance abuse.I haven't been hospitalized or had severe COPD symptoms needing treatment in the last 30 days.I have not been treated for advanced cancer in the last 60 days.My care partner is someone close to me and not paid.I do not have other lung conditions like asthma or bronchiectasis.I have COPD confirmed by a breathing test showing specific results.My care partner is 18 years old or older.My care partner does not have hearing problems that can't be fixed.
Research Study Groups:
This trial has the following groups:- Group 1: Usual COPD Care
- Group 2: Intervention (EPIC plus Usual COPD Care)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger